T cell-specific loss of Pten leads to defects in central and peripheral tolerance

Immunity

Volumn 14, Issue 5, 2001, Pages 523-534

  Suzuki, Akira ^a,e,f   Yamaguchi, Manae Tsukio ^a   Ohteki, Toshiaki ^c   Sasaki, Takehiko ^f   Kaisho, Tsuneyasu ^b,f   Kimura, Yuki ^f   Higuchi, Tetsuya ^d   Fukumoto, Manabu ^e   Ohashi, Pamela S ^g   Tsubata, Takeshi ^d   Koyasu, Shigeo ^c   Nakano, Toru ^a   Mak, Tak W ^f  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^e TOHOKU UNIVERSITY   (Japan)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; STAPHYLOCOCCUS ENTEROTOXIN B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL LEVEL; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO DEVELOPMENT; FEMALE; HOMEOSTASIS; HYPERGAMMAGLOBULINEMIA; IMMUNOLOGICAL TOLERANCE; LYMPHADENOPATHY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SPLENOMEGALY; T CELL LYMPHOMA; T LYMPHOCYTE; THYMUS HYPERPLASIA; TUMOR SUPPRESSOR GENE;

EID: 0034995242     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(01)00134-0     Document Type: Article

References (49)

1. Increased phosphoinositide 3-kinase activity induces a lymphoproliferative disorder and contributes to tumor generation in vivo
2. Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3
3. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
4. Interleukin-3 induces phosphorylation of BAD through the protein kinase AKT
5. Pten is essential for embryonic development and tumour suppression
6. Impaired Fas response and autoimmunity in Pten+/- mice
7. Rapid induction of transcription of unrearranged S gamma 1 switch regions in activated murine B cells by interleukin 4
8. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha
9. PTEN transcriptionally modulates c-myc gene expression in human breast carcinoma cells and is involved in cell growth regulation
10. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting
11. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways
12. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC
13. T-cell-specific deletion of a polypeptide N-acetylgalactosaminyl-transferse gene by site-directed recombination
14. Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and bcl-X(L) levels in vivo
15. The roles of gamma 1 heavy chain membrane expression and cytoplasmic tail in IgG1 responses
16. T cell tolerance by clonal elimination in the thymus
17. Programmed cell death and extrathymic reduction of Vbeta8+ CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B
18. Selective development of CD4+ T cells in transgenic mice expressing a class II MHC-restricted antigen receptor
19. Reduction of lupus nephritis in MRL/lpr mice by a bacterial superantigen treatment
20. Landscaping the cancer terrain
21. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes
22. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
23. PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells
24. Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk
25. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
26. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3, 4, 5-trisphosphate
27. Germline mutations in PTEN are present in Bannayan-Zonana syndrome
28. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome
29. The lipid phosphatase activity of PTEN is critical for its tumor supressor function
30. Akt/protein kinase B isoforms are differentially regulated by epidermal growth factor stimulation
31. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase
32. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems
33. Akt/protein kinase B up-regulates Bcl-2 expression through camp-response element-binding protein
34. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling
35. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration
36. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane
37. Selection of the T cell repertoire
38. Deficiency of Pten in Jurkat T cells causes constitutive localization of Itk to the plasma membrane and hyperresponsiveness to CD3 stimulation
39. Commitment to the CD4 lineage mediated by extracellular signal-related kinase mitogen-activated protein kinase and lck-signaling
40. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
41. Mononuclear-cell pulmonary vasculitis in NZB/W mice. I. Histopathologic evaluation of spontaneously occurring pulmonary infiltrates
42. Differential roles of ERK and p38 MAP kinase pathways in positive and negative selection of T lymphocytes
43. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice
44. Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase
45. Thymic major histocompatibility complex antigens and the alpha beta T-cell receptor determine the CD4/CD8 phenotype of T cells
46. Signalling through the lipid products of phosphoinositide-3-OH kinase
47. Do autoimmune diseases raise the risk of cancer?
48. Extrathymic tolerance of mature cells: Clonal elimination as a consequence of Immunity
49. + T-cell lineage fate